Shuttle Pharma CFO files Form 3, reports no holdings

Shuttle Pharmaceuticals Holdings, Inc. Chief Financial Officer Yuying Liang has filed an initial insider ownership report on Form 3.

Accepted by SEC EDGAR 01/12/2026 - 04:15 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Shuttle Pharmaceuticals Holdings, Inc. Chief Financial Officer Yuying Liang has filed an initial insider ownership report on Form 3. The filing states that no securities of Shuttle Pharmaceuticals are beneficially owned, and both the non-derivative and derivative securities tables contain no holdings. This is a routine disclosure establishing that, as of the event date, the CFO reports no direct or indirect ownership of the company’s stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Shuttle Pharmaceuticals (SHPH) CFO report in this Form 3?

The Form 3 states that Chief Financial Officer Yuying Liang has no securities beneficially owned in Shuttle Pharmaceuticals Holdings, Inc.

Does this Shuttle Pharmaceuticals Form 3 show any insider stock transactions?

No. The filing includes no transactions, and both the non-derivative and derivative securities tables list no holdings.

What is the relationship of the reporting person to Shuttle Pharmaceuticals (SHPH)?

The reporting person, Yuying Liang, is identified as an officer of Shuttle Pharmaceuticals Holdings, Inc., serving as Chief Financial Officer.

What is the event date for this Shuttle Pharmaceuticals Form 3?

The Form 3 lists the Date of Event Requiring Statement as 01/06/2026.

Is this Shuttle Pharmaceuticals Form 3 filed by more than one reporting person?

No. The form indicates it is filed by one reporting person, not a group filing.

What does it mean that no securities are beneficially owned in this Form 3?

The explanation of responses explicitly states “No securities are beneficially owned.” This means the CFO reports no direct or indirect ownership of Shuttle Pharmaceuticals securities as of the reported event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liang Yuying

(Last) (First) (Middle)

C/O SHUTTLE PHARMACEUTICALS HOLDINGS

401 PROFESSIONAL DRIVE, SUITE 260

(Street)

GAITHERSBURG MD 20879

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/06/2026

3. Issuer Name and Ticker or Trading Symbol
Shuttle Pharmaceuticals Holdings, Inc. [ SHPH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Yuying Liang	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.